Carey Chern, JD, is an Executive in Residence at Bay City Capital, and joined the firm in 2018. As a law firm attorney, Carey worked with Bay City Capital to help launch the firm in 1997, and worked on fund formation and on portfolio company investments for the first five investment funds. He contributes over two decades of legal and transactional pharmaceutical and diagnostics experience to the firm. Mr. Chern works closely with the Bay City Capital team on its current investment funds and portfolio companies, as well as its future investment fund formation opportunities. He is also assisting on incubating an AI/database life sciences company. Prior to working at Bay City Capital, he was General Counsel, Chief Compliance Officer and Corporate Secretary for SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN), which was taken private by a private equity firm in 2017. He has served as division counsel at Clorox for its Professional Products Division (primarily healthcare), as senior corporate counsel at Amgen, and as an attorney at AmLaw100 global law firms. Mr. Chern earned an AB in Economics and Government from Harvard University and a JD from Stanford Law School. He is admitted to practice law in California.